Entheon Biomedical Corp.
ENTBF
$0.081
-$0.0035-4.14%
OTC PK
| 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | 0.00 |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | 0.00 |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | 0.00 |
| SG&A Expenses | 62.10K | 49.10K | 74.90K | 58.00K | 54.80K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 62.10K | 49.10K | 74.90K | 58.00K | 54.80K |
| Operating Income | -62.10K | -49.10K | -74.90K | -58.00K | -54.80K |
| Income Before Tax | -60.90K | -47.20K | -69.40K | -55.70K | -53.90K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -60.90K | -47.20K | -69.40K | -55.70K | -53.90K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -60.90K | -47.20K | -69.40K | -55.70K | -53.90K |
| EBIT | -62.10K | -49.10K | -74.90K | -58.00K | -54.80K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 8.85M | 8.86M | 7.32M | 5.91M | 5.91M |
| Average Diluted Shares Outstanding | 8.85M | 8.86M | 7.32M | 5.91M | 5.91M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |